# Melatonin's Effects on Treatment Of Diabetes Mellitus

> **NCT02691897** · EARLY_PHASE1 · UNKNOWN · sponsor: **Shiraz University of Medical Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02691897
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07
- **Primary completion:** 2020-05
- **Final completion:** 2020-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02691897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02691897, "Melatonin's Effects on Treatment Of Diabetes Mellitus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02691897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*